Showing results (331-340 of 520) with videos related to
Sort By:
Pageof 52
Cardiovascular & Hematological Agents in Medicinal Chemistry|November 6, 2007
Pharmacological activity of cardiovascular agents from herbal medicineJohn W Ho, Meng JieCardiovascular & Hematological Agents in Medicinal Chemistry|November 6, 2007
Porphyrin-photosensitized processes: their applications in the prevention of arterial restenosisM Magaraggia, L Marigo, A Pagnan, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|November 6, 2007
Targeting the sarcolemmal calcium pump: a potential novel strategy for the treatment of cardiovascular diseaseDelvac Oceandy, Mamas A Mamas, Ludwig NeysesCardiovascular & Hematological Agents in Medicinal Chemistry|July 17, 2007
Management of cardiovascular risk factors in patients with metabolic syndromeAlejandro de la Sierra, Luis Miguel RuilopeCardiovascular & Hematological Agents in Medicinal Chemistry|April 10, 2009
Recent developments in pharmacologic prophylaxis of atrial fibrillation in patients undergoing surgical revascularizationCarlo RostagnoCardiovascular & Hematological Agents in Medicinal Chemistry|April 10, 2009
Contrast medium induced nephropathy: new insights into prevention and risk managementM Vercellino, G P Bezante, M BalbiCardiovascular & Hematological Agents in Medicinal Chemistry|December 12, 2023
Study of the Antihypertensive Effect of Scorzonera undulata ssp. deliciosa in Albino Wistar RatsAyoub Amssayef, Mohammed Ajebli, Mohamed EddouksCardiovascular & Hematological Agents in Medicinal Chemistry|January 23, 2024
The Genus Anabasis: A Review on Pharmacological and Phytochemical PropertiesSmail Amtaghri, Miloudia Slaoui, Mohamed EddouksCardiovascular & Hematological Agents in Medicinal Chemistry|January 24, 2024
MicroRNAs Targeting Critical Molecular Pathways in Diabetic Cardiomyopathy Emerging Valuable for TherapyPriyanka Mathur, Sharad Saxena, Bhawna Saxena, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|January 26, 2024
Efficacy of Dyslipidemia Control by Combination Therapy with Rosuvastatin 10 Mg and Ezetimibe 10 Mg Compared with Rosuvastatin 20 Mg Monotherapy in Patients with Chronic Coronary Syndromes: A Randomized, Single-blind Controlled TrialAn Viet Tran, Bao Lam Thai Tran, Nghia Minh Bui, et al.Pageof 52